Drug search by name
Canakinumab Subcutaneous and Glycerol phenylbutyrate
Determining the interaction of Canakinumab Subcutaneous and Glycerol phenylbutyrate and the possibility of their joint administration.
Check result:
Canakinumab Subcutaneous <> Glycerol phenylbutyrate
Relevance: 24.10.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Canakinumab Subcutaneous
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Glycerol phenylbutyrate
Generic Name: glycerol phenylbutyrate
Brand name: Ravicti
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Canakinumab Subcutaneous-GlycoLax
- Canakinumab Subcutaneous-Glycophos
- Canakinumab Subcutaneous-Glycophos Injection
- Canakinumab Subcutaneous-Glycopyrrolate
- Canakinumab Subcutaneous-Glycopyrrolate (Oral Inhalation)
- Canakinumab Subcutaneous-Glycopyrrolate (Systemic)
- Glycerol phenylbutyrate-Canasa
- Glycerol phenylbutyrate-Canasa Pac rectal
- Glycerol phenylbutyrate-Canasa rectal
- Glycerol phenylbutyrate-Cancidas
- Glycerol phenylbutyrate-Candesartan
- Glycerol phenylbutyrate-Candesartan and Hydrochlorothiazide
Doktika World
Interaction with food and lifestyle
Disease interaction